Intrinsic value of Health Insurance Innovations Cl A - HIIQ

Previous Close

$33.10

  Intrinsic Value

$189.16

stock screener

  Rating & Target

str. buy

+471%

  Value-price divergence*

+142%

Previous close

$33.10

 
Intrinsic value

$189.16

 
Up/down potential

+471%

 
Rating

str. buy

 
Value-price divergence*

+142%

Our model is not good at valuating stocks of financial companies, such as HIIQ.

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of HIIQ stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 0.5

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  76.19
  33.30
  30.47
  27.92
  25.63
  23.57
  21.71
  20.04
  18.54
  17.18
  15.96
  14.87
  13.88
  12.99
  12.19
  11.47
  10.83
  10.24
  9.72
  9.25
  8.82
  8.44
  8.10
  7.79
  7.51
  7.26
  7.03
  6.83
  6.65
  6.48
  6.33
Revenue, $m
  0
  247
  322
  412
  517
  639
  778
  934
  1,107
  1,297
  1,504
  1,727
  1,967
  2,223
  2,494
  2,780
  3,081
  3,396
  3,726
  4,071
  4,430
  4,804
  5,193
  5,597
  6,018
  6,454
  6,908
  7,380
  7,870
  8,380
  8,911
Variable operating expenses, $m
 
  184
  239
  304
  381
  470
  571
  684
  811
  949
  1,100
  1,259
  1,434
  1,620
  1,817
  2,026
  2,245
  2,475
  2,716
  2,967
  3,229
  3,501
  3,785
  4,080
  4,386
  4,704
  5,035
  5,379
  5,736
  6,108
  6,495
Fixed operating expenses, $m
 
  29
  29
  30
  31
  32
  32
  33
  34
  35
  36
  37
  38
  39
  40
  41
  42
  43
  44
  45
  46
  47
  48
  49
  51
  52
  53
  55
  56
  57
  59
Total operating expenses, $m
  166
  213
  268
  334
  412
  502
  603
  717
  845
  984
  1,136
  1,296
  1,472
  1,659
  1,857
  2,067
  2,287
  2,518
  2,760
  3,012
  3,275
  3,548
  3,833
  4,129
  4,437
  4,756
  5,088
  5,434
  5,792
  6,165
  6,554
Operating income, $m
  18
  34
  54
  77
  105
  137
  174
  216
  262
  313
  368
  432
  496
  564
  637
  713
  794
  878
  967
  1,059
  1,155
  1,256
  1,360
  1,468
  1,581
  1,698
  1,820
  1,947
  2,078
  2,215
  2,358
EBITDA, $m
  21
  39
  59
  83
  111
  144
  181
  223
  270
  321
  377
  438
  503
  572
  646
  723
  805
  891
  980
  1,074
  1,172
  1,273
  1,379
  1,489
  1,603
  1,722
  1,845
  1,974
  2,107
  2,246
  2,390
Interest expense (income), $m
  0
  0
  1
  2
  3
  5
  7
  9
  11
  13
  16
  19
  22
  26
  30
  34
  38
  42
  47
  52
  57
  62
  67
  73
  79
  85
  91
  98
  105
  112
  119
Earnings before tax, $m
  8
  34
  53
  75
  102
  133
  168
  207
  251
  299
  352
  412
  473
  538
  607
  680
  756
  836
  920
  1,008
  1,099
  1,194
  1,293
  1,395
  1,502
  1,613
  1,729
  1,849
  1,973
  2,103
  2,238
Tax expense, $m
  -5
  9
  14
  20
  28
  36
  45
  56
  68
  81
  95
  111
  128
  145
  164
  183
  204
  226
  248
  272
  297
  322
  349
  377
  406
  436
  467
  499
  533
  568
  604
Net income, $m
  5
  25
  39
  55
  74
  97
  122
  151
  183
  218
  257
  301
  345
  393
  443
  496
  552
  610
  672
  735
  802
  871
  944
  1,019
  1,097
  1,178
  1,262
  1,350
  1,441
  1,535
  1,634

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  125
  167
  217
  278
  349
  432
  525
  631
  748
  876
  1,016
  1,167
  1,329
  1,502
  1,685
  1,878
  2,081
  2,295
  2,518
  2,751
  2,993
  3,246
  3,509
  3,782
  4,066
  4,361
  4,668
  4,986
  5,318
  5,662
  6,021
Adjusted assets (=assets-cash), $m
  125
  167
  217
  278
  349
  432
  525
  631
  748
  876
  1,016
  1,167
  1,329
  1,502
  1,685
  1,878
  2,081
  2,295
  2,518
  2,751
  2,993
  3,246
  3,509
  3,782
  4,066
  4,361
  4,668
  4,986
  5,318
  5,662
  6,021
Revenue / Adjusted assets
  0.000
  1.479
  1.484
  1.482
  1.481
  1.479
  1.482
  1.480
  1.480
  1.481
  1.480
  1.480
  1.480
  1.480
  1.480
  1.480
  1.481
  1.480
  1.480
  1.480
  1.480
  1.480
  1.480
  1.480
  1.480
  1.480
  1.480
  1.480
  1.480
  1.480
  1.480
Average production assets, $m
  12
  16
  21
  27
  34
  42
  51
  61
  72
  84
  98
  112
  128
  144
  162
  181
  200
  221
  242
  265
  288
  312
  338
  364
  391
  420
  449
  480
  512
  545
  579
Working capital, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total debt, $m
  0
  26
  57
  94
  138
  189
  247
  312
  384
  463
  549
  642
  742
  848
  961
  1,080
  1,205
  1,337
  1,474
  1,617
  1,767
  1,922
  2,084
  2,253
  2,428
  2,609
  2,798
  2,995
  3,199
  3,411
  3,632
Total liabilities, $m
  77
  103
  134
  171
  215
  266
  324
  389
  461
  540
  626
  719
  819
  925
  1,038
  1,157
  1,282
  1,414
  1,551
  1,694
  1,844
  1,999
  2,161
  2,330
  2,505
  2,686
  2,875
  3,072
  3,276
  3,488
  3,709
Total equity, $m
  48
  64
  83
  107
  134
  166
  202
  242
  287
  336
  390
  448
  510
  577
  647
  721
  799
  881
  967
  1,056
  1,149
  1,246
  1,347
  1,452
  1,561
  1,675
  1,792
  1,915
  2,042
  2,174
  2,312
Total liabilities and equity, $m
  125
  167
  217
  278
  349
  432
  526
  631
  748
  876
  1,016
  1,167
  1,329
  1,502
  1,685
  1,878
  2,081
  2,295
  2,518
  2,750
  2,993
  3,245
  3,508
  3,782
  4,066
  4,361
  4,667
  4,987
  5,318
  5,662
  6,021
Debt-to-equity ratio
  0.000
  0.400
  0.680
  0.880
  1.030
  1.140
  1.220
  1.290
  1.340
  1.380
  1.410
  1.430
  1.450
  1.470
  1.490
  1.500
  1.510
  1.520
  1.520
  1.530
  1.540
  1.540
  1.550
  1.550
  1.550
  1.560
  1.560
  1.560
  1.570
  1.570
  1.570
Adjusted equity ratio
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384
  0.384

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  5
  25
  39
  55
  74
  97
  122
  151
  183
  218
  257
  301
  345
  393
  443
  496
  552
  610
  672
  735
  802
  871
  944
  1,019
  1,097
  1,178
  1,262
  1,350
  1,441
  1,535
  1,634
Depreciation, amort., depletion, $m
  3
  5
  5
  6
  6
  6
  7
  8
  8
  9
  10
  6
  7
  8
  9
  10
  11
  12
  14
  15
  16
  18
  19
  21
  22
  24
  25
  27
  29
  31
  33
Funds from operations, $m
  24
  30
  44
  61
  80
  103
  129
  159
  191
  227
  266
  307
  353
  401
  452
  506
  563
  623
  685
  750
  818
  889
  963
  1,039
  1,119
  1,201
  1,287
  1,377
  1,469
  1,566
  1,667
Change in working capital, $m
  6
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from operations, $m
  18
  30
  44
  61
  80
  103
  129
  159
  191
  227
  266
  307
  353
  401
  452
  506
  563
  623
  685
  750
  818
  889
  963
  1,039
  1,119
  1,201
  1,287
  1,377
  1,469
  1,566
  1,667
Maintenance CAPEX, $m
  0
  -1
  -1
  -1
  -2
  -2
  -2
  -3
  -3
  -4
  -5
  -6
  -6
  -7
  -8
  -9
  -10
  -11
  -12
  -14
  -15
  -16
  -18
  -19
  -21
  -22
  -24
  -25
  -27
  -29
  -31
New CAPEX, $m
  -3
  -4
  -5
  -6
  -7
  -8
  -9
  -10
  -11
  -12
  -13
  -15
  -16
  -17
  -18
  -19
  -20
  -21
  -21
  -22
  -23
  -24
  -25
  -26
  -27
  -28
  -29
  -31
  -32
  -33
  -34
Cash from investing activities, $m
  -3
  -5
  -6
  -7
  -9
  -10
  -11
  -13
  -14
  -16
  -18
  -21
  -22
  -24
  -26
  -28
  -30
  -32
  -33
  -36
  -38
  -40
  -43
  -45
  -48
  -50
  -53
  -56
  -59
  -62
  -65
Free cash flow, $m
  15
  25
  38
  54
  72
  93
  118
  146
  177
  211
  248
  287
  331
  377
  426
  479
  533
  591
  651
  714
  780
  849
  920
  994
  1,071
  1,151
  1,234
  1,321
  1,411
  1,504
  1,601
Issuance/(repayment) of debt, $m
  -8
  26
  31
  37
  44
  51
  58
  65
  72
  79
  86
  93
  100
  106
  113
  119
  125
  131
  137
  143
  149
  156
  162
  168
  175
  182
  189
  196
  204
  212
  221
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  -10
  26
  31
  37
  44
  51
  58
  65
  72
  79
  86
  93
  100
  106
  113
  119
  125
  131
  137
  143
  149
  156
  162
  168
  175
  182
  189
  196
  204
  212
  221
Total cash flow (excl. dividends), $m
  5
  51
  69
  91
  116
  144
  176
  211
  249
  290
  334
  380
  431
  484
  539
  598
  659
  722
  789
  858
  930
  1,004
  1,082
  1,162
  1,246
  1,333
  1,423
  1,517
  1,615
  1,716
  1,822
Retained Cash Flow (-), $m
  -8
  -16
  -19
  -23
  -27
  -32
  -36
  -40
  -45
  -49
  -54
  -58
  -62
  -66
  -70
  -74
  -78
  -82
  -86
  -89
  -93
  -97
  -101
  -105
  -109
  -113
  -118
  -122
  -127
  -132
  -138
Prev. year cash balance distribution, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  35
  50
  68
  89
  113
  140
  170
  204
  241
  281
  322
  368
  417
  469
  523
  581
  640
  703
  768
  836
  907
  981
  1,057
  1,137
  1,219
  1,305
  1,395
  1,487
  1,584
  1,685
Discount rate, %
 
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
 
  33
  46
  59
  73
  87
  101
  115
  127
  138
  147
  153
  157
  159
  157
  154
  148
  139
  129
  118
  106
  94
  81
  69
  58
  47
  38
  30
  23
  17
  13
Current shareholders' claim on cash, %
  100
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Health Insurance Innovations, Inc. operates as a developer, distributor, and administrator of cloud-based individual health and family insurance plans, and supplemental products in the United States. The company offers short-term medical plans that cover individuals for up to 364 days with various co-pay and deductible options; hospital indemnity plans, which provide a daily cash benefit for hospital treatment and doctor office visits, as well as accidental injury and death or dismemberment benefits; and supplemental insurance products comprising pharmacy benefit cards, dental plans, vision plans, and cancer/critical illness plans, as well as deductible and gap protection plans, and life insurance policies. It designs and structures insurance and non-insurance products on behalf of insurance carriers; and markets them to individuals through a network of distributors. Health Insurance Innovations, Inc. was founded in 2008 and is based in Tampa, Florida.

FINANCIAL RATIOS  of  Health Insurance Innovations Cl A (HIIQ)

Valuation Ratios
P/E Ratio 98.5
Price to Sales 2.7
Price to Book 10.3
Price to Tangible Book
Price to Cash Flow 27.4
Price to Free Cash Flow 32.8
Growth Rates
Sales Growth Rate 76.2%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 50%
Cap. Spend. - 3 Yr. Gr. Rate NaN%
Financial Strength
Quick Ratio NaN
Current Ratio NaN
LT Debt to Equity 0%
Total Debt to Equity 0%
Interest Coverage 0
Management Effectiveness
Return On Assets 4.5%
Ret/ On Assets - 3 Yr. Avg. 1.9%
Return On Total Capital 10.4%
Ret/ On T. Cap. - 3 Yr. Avg. 4.2%
Return On Equity 11.4%
Return On Equity - 3 Yr. Avg. 4.6%
Asset Turnover 1.7
Profitability Ratios
Gross Margin 0%
Gross Margin - 3 Yr. Avg. 0%
EBITDA Margin 5.9%
EBITDA Margin - 3 Yr. Avg. 4.1%
Operating Margin 10.3%
Oper. Margin - 3 Yr. Avg. 3.9%
Pre-Tax Margin 4.3%
Pre-Tax Margin - 3 Yr. Avg. 1.8%
Net Profit Margin 2.7%
Net Profit Margin - 3 Yr. Avg. 1.2%
Effective Tax Rate -62.5%
Eff/ Tax Rate - 3 Yr. Avg. 12.5%
Payout Ratio 0%

HIIQ stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the HIIQ stock intrinsic value calculation we used $185 million for the last fiscal year's total revenue generated by Health Insurance Innovations Cl A. The default revenue input number comes from 2016 income statement of Health Insurance Innovations Cl A. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our HIIQ stock valuation model: a) initial revenue growth rate of 33.3% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for HIIQ is calculated based on our internal credit rating of Health Insurance Innovations Cl A, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Health Insurance Innovations Cl A.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of HIIQ stock the variable cost ratio is equal to 75.1%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $28 million in the base year in the intrinsic value calculation for HIIQ stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 3.5% for Health Insurance Innovations Cl A.

Corporate tax rate of 27% is the nominal tax rate for Health Insurance Innovations Cl A. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the HIIQ stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for HIIQ are equal to 6.5%.

Life of production assets of 17.7 years is the average useful life of capital assets used in Health Insurance Innovations Cl A operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for HIIQ is equal to 0%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $48 million for Health Insurance Innovations Cl A - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 15.045 million for Health Insurance Innovations Cl A is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Health Insurance Innovations Cl A at the current share price and the inputted number of shares is $0.5 billion.

RELATED COMPANIES Price Int.Val. Rating
EHTH eHealth 17.74 12.72  sell
UNH UnitedHealth G 190.82 203.69  hold
BRO Brown&Brown 43.63 89.30  str.buy
AJG Arthur J. Gall 57.94 80.18  buy
AFL AFLAC 79.84 187.44  str.buy

COMPANY NEWS

▶ These Stocks Have Quadrupled Since Last Year   [Aug-18-17 07:17AM  Motley Fool]
▶ Three Stocks Breaking Out   [12:58PM  Benzinga]
▶ Health Insurance Innovations posts 2Q profit   [Aug-02-17 11:07PM  Associated Press]
▶ Shark Bites: Market Gains Aren't Slipping Away   [Jul-13-17 01:55PM  TheStreet.com]
▶ Tampa Bay's hottest stock market performers for the first half of 2017   [Jul-03-17 02:57PM  American City Business Journals]
▶ No Headlines? No Problem for This Market   [Jun-19-17 11:26AM  TheStreet.com]
▶ Algos Trade for Pennies, Not for Big Moves on News   [Jun-14-17 10:48AM  TheStreet.com]
▶ 3 Small Cap-Growth Stocks You Can Buy Now   [May-17-17 08:02AM  Motley Fool]
▶ Shark Bites: Market Isn't a Morning Person   [May-12-17 12:10PM  TheStreet.com]
▶ OK, Who's Hiding the Market Momentum?   [May-08-17 11:14AM  TheStreet.com]
▶ S&P 500 Needs a Defibrillator: Clear!   [12:11PM  TheStreet.com]
▶ Health Insurance Innovations posts 1Q profit   [May-03-17 05:36PM  Associated Press]
▶ Why Health Insurance Innovations Is Tumbling 10% Today   [Mar-08-17 02:06PM  at Motley Fool]
Stock chart of HIIQ Financial statements of HIIQ
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.